A third dose of the unmodified COVID-19 mRNA vaccine CVnCoV enhances quality and quantity of immune responses-Reference-Cited by-同舟云学术

A third dose of the unmodified COVID-19 mRNA vaccine CVnCoV enhances quality and quantity of immune responses

Published:2022-12 Issue: Volume:27 Page:309-323
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Lenart Klara,Hellgren Fredrika,Ols Sebastian,Yan Xianglei,Cagigi Alberto,Cerveira Rodrigo Arcoverde,Winge Inga,Hanczak Jakub,Mueller Stefan O.,Jasny Edith,Schwendt Kim,Rauch Susanne,Petsch Benjamin,Loré Karin

Funder

China Scholarship Council

Bill and Melinda Gates Foundation

Coalition for Epidemic Preparedness Innovations

Karolinska Institutet

Knut och Alice Wallenbergs Stiftelse

Vetenskapsrådet

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference72 articles.

1. Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial;Kremsner;Lancet Infect. Dis.,2022

2. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine;Polack;N. Engl. J. Med.,2020

3. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine;Baden;N. Engl. J. Med. Overseas. Ed.,2021

4. Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2;Kremsner;Wien Klin. Wochenschr.,2021

5. Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccine;Gebre;Nature,2022

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cellular and humoral response to SARS-CoV-2 vaccine BNT162b2 in adults with Chronic Kidney Disease G4/5.;New Microbes and New Infections;2024-12

2. Rational optimization of glycoprotein E (gE)-encoding mRNA for improved Varicella-zoster virus mRNA vaccine development;Emerging Microbes & Infections;2024-09-12

3. Lipid nanoparticle encapsulation of a Delta spike-CD40L DNA vaccine improves effectiveness against Omicron challenge in Syrian hamsters;Molecular Therapy - Methods & Clinical Development;2024-09

4. Advancement in the development of mRNA‐based vaccines for respiratory viruses;Immunology;2024-08-19

5. A new approach to RNA synthesis: immobilization of stably and functionally co-tethered promoter DNA and T7 RNA polymerase;Nucleic Acids Research;2024-07-16